In this review, we discuss the discovery and biologic significance of HE4 and evaluate available evidence regarding the utility of HE4 as a biomarker for ovarian and endometrial cancer.
Keith Baggerly, PhD
Advertisement
Articles by Keith Baggerly, PhD
Advertisement
Latest Updated Articles
The Emerging Role of HE4 in the Evaluation of Epithelial Ovarian and Endometrial CarcinomasPublished: June 15th 2013 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
ESMO 2025: The Top 10 Takeaways That May Shift Oncology Practice
2
Frontline Tislelizumab Combo Improves Long-Term Survival in ES-SCLC
3
ctDNA Status May Determine Adjuvant Immunotherapy Benefit in MIBC
4
Awareness Fuels Progress: Upcoming Advances in Breast Cancer Treatment
5
